During the past decade, GenesisCare Ringwood conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GenesisCare Ringwood" are "Atherosclerotic Cardiovascular Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "GenesisCare Ringwood" in a lesser frequency.

Most popular intervention types in "GenesisCare Ringwood" are "Other" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Finerenone (BAY94-8862)" (1 trials), "Lp(a) Screening" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare Ringwood" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GenesisCare Ringwood". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GenesisCare Ringwood, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare Ringwood, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".